BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/30/2021 10:10:27 AM | Browse: 993 | Download: 1821
Publication Name World Journal of Clinical Cases
Manuscript ID 59983
Country Taiwan
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Retrospective Study
Article Title Biochemical recurrence analysis of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance
Manuscript Source Unsolicited Manuscript
All Author List Che Hseuh Yang, Yi Sheng Lin, Yen Chuan Ou, Wei Chun Weng, Li Hua Huang, Chin Heng Lu, Chao Yu Hsu and Min Che Tung
ORCID
Author(s) ORCID Number
Che Hseuh Yang http://orcid.org/0000-0003-2251-3379
Yi Sheng Lin http://orcid.org/0000-0003-0592-0036
Yen Chuan Ou http://orcid.org/0000-0002-6080-7231
Wei Chun Weng http://orcid.org/0000-0002-8844-4882
Li Hua Huang http://orcid.org/0000-0003-4337-7230
Chin Heng Lu http://orcid.org/0000-0003-3707-6423
Chao Yu Hsu http://orcid.org/0000-0001-9809-7442
Min Che Tung http://orcid.org/0000-0002-4136-7613
Funding Agency and Grant Number
Corresponding Author Yi Sheng Lin, MD, Attending Doctor, Surgeon, Surgical Oncologist, Division of Urology, Department of Surgery, Tungs' Taichung MetroHarbor Hospital, No. 699 Sec. 8, Taiwan Blvd, Wuqi District, Taichung 435403, Taiwan. tung12197@gmail.com
Key Words Prostatectomy/methods; Robotic surgical procedures; Prostatic neoplasms/pathology; Prostate-specific antigen/metabolism; Margins of excision; Retrospective study
Core Tip The term pT2+ is coined in 2004 and for prostate cancer (PCa) of positive surgical margin (PSM) but without extracapsular extension. Although PSM is deemed to be an adverse effect, it is inconclusive whether adjuvant radiotherapy (aRT) is imperative. From this real-world experience, we conclude that robotic-assisted approach can benefit the patients of worse conditions with non-inferior prognosis, and preoperative prostate specific antigen cut-off value of 19.09 ng/mL can be utilized a predictive factor of biochemical recurrence after surgery. At the same time, we are not in favor of routine aRT to pT2+ PCa.
Publish Date 2021-01-30 10:10
Citation Yang CH, Lin YS, Ou YC, Weng WC, Huang LH, Lu CH, Hsu CY, Tung MC. Biochemical recurrence analysis of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance. World J Clin Cases 2021; 9(5): 1026-1036
URL https://www.wjgnet.com/2307-8960/full/v9/i5/1026.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i5.1026
Full Article (PDF) WJCC-9-1026.pdf
Full Article (Word) WJCC-9-1026.docx